Company intelligence / Profile preview

Certus Imaging

Ownership: Private
Development stage: Other

Overview

Certus is a biotechnology and medical device company focused on developing advanced image-guided therapies for oncology. The company's core technology integrates real-time imaging with targeted therapeutic delivery to improve the precision and efficacy of cancer treatments. By leveraging sophisticated imaging modalities, Certus aims to provide clinicians with better tools for visualizing tumors and monitoring treatment response in real-time. Their approach is designed to minimize off-target effects and enhance the therapeutic window for various cancer types.

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceutical
Industry: Biotech

Beyond the preview

Go deeper on Certus Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Certus Imaging.

Explore the full profile